EA201290902A1 - Молочно-кислые бактерии, применяемые при чревной болезни - Google Patents

Молочно-кислые бактерии, применяемые при чревной болезни

Info

Publication number
EA201290902A1
EA201290902A1 EA201290902A EA201290902A EA201290902A1 EA 201290902 A1 EA201290902 A1 EA 201290902A1 EA 201290902 A EA201290902 A EA 201290902A EA 201290902 A EA201290902 A EA 201290902A EA 201290902 A1 EA201290902 A1 EA 201290902A1
Authority
EA
Eurasian Patent Office
Prior art keywords
evaporial
dairy
diseases
acid bacteria
bacteria applied
Prior art date
Application number
EA201290902A
Other languages
English (en)
Other versions
EA031179B1 (ru
Inventor
Агусти Монтсеррат Каррерас
Монтсеррат Андреу Короминас
Даниэль Рамон Видаль
Сальвадор Хеновес Мартинес
Эстер Батальер Лейва
Original Assignee
Компани Жервэ Данон
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Компани Жервэ Данон filed Critical Компани Жервэ Данон
Publication of EA201290902A1 publication Critical patent/EA201290902A1/ru
Publication of EA031179B1 publication Critical patent/EA031179B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/18—Baker's yeast; Brewer's yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Настоящее изобретение относится к штаммам Lactobacillus и Streptococcus, которые способны расщеплять пептиды глиадина, участвующие в патогенезе чревной болезни, и активность расщепления пептидов которых устойчива в условиях низкого рН и в присутствии пищеварительных ферментов млекопитающих. Эти штаммы подходят для включения в продукт, применяемый при профилактике и/или лечении чревной болезни.
EA201290902A 2010-03-12 2010-03-12 Молочнокислые бактерии, применяемые при чревной болезни EA031179B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2010/000699 WO2011110884A1 (en) 2010-03-12 2010-03-12 Lactic acid bacteria for coeliac disease

Publications (2)

Publication Number Publication Date
EA201290902A1 true EA201290902A1 (ru) 2013-04-30
EA031179B1 EA031179B1 (ru) 2018-11-30

Family

ID=42983265

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201290902A EA031179B1 (ru) 2010-03-12 2010-03-12 Молочнокислые бактерии, применяемые при чревной болезни

Country Status (7)

Country Link
US (2) US20130121976A1 (ru)
EP (1) EP2545160B1 (ru)
CN (1) CN103097513B (ru)
BR (1) BR112012023028B1 (ru)
EA (1) EA031179B1 (ru)
ES (1) ES2691301T3 (ru)
WO (1) WO2011110884A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10039296B2 (en) 2011-06-20 2018-08-07 H.J. Heinz Company Brands Llc Probiotic compositions and methods
DK2861242T3 (en) * 2012-06-18 2018-10-29 Heinz Co Brands H J Llc GLUTEN RELATED DISORDERS
WO2014044281A1 (en) 2012-09-19 2014-03-27 Rigshospitalet Inhibition of a 33-mer gliadin peptide for treatment of diabetes
CA2897742A1 (en) * 2013-02-19 2014-08-28 Danone, S.A. Functional peptides for obesity disorders
PL2994150T3 (pl) 2013-05-10 2019-09-30 H.J. Heinz Company Brands Llc Probiotyki i sposoby zastosowania
DK3146037T3 (en) * 2014-05-23 2018-07-30 Consejo Superior Investigacion NEW LACTOBACILLUS CASEI STREAMS WITH ABILITY TO DESTROY THE GLUTEN IMMUNOTOXIC PEPTID
FI127483B (en) 2014-06-11 2018-07-13 Gut Guide Oy Microbial marker for celiac disease and related product
WO2016177701A1 (en) * 2015-05-07 2016-11-10 Compagnie Gervais Danone Acid whey with stable lactose content
IT201900014550A1 (it) * 2019-08-09 2021-02-09 Abiogen Pharma Spa Uso di colecalciferolo come agente attivo nel trattamento della celiachia
US20230042485A1 (en) 2019-12-23 2023-02-09 Evonik Operations Gmbh Process to identify consortia of probiotic strains suitable for gluten degradation
CN112056496A (zh) * 2020-09-09 2020-12-11 中国农业大学 一种利用乳酸菌降低面团麸质蛋白含量的方法
CN114657091B (zh) * 2022-03-03 2023-08-11 中国疾病预防控制中心传染病预防控制所 一种弯曲菌增菌培养液及其制备方法、应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809312B1 (fr) * 2000-05-25 2002-07-12 Gervais Danone Sa Utilisation de l. casei dans des compositions immunostimulantes
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
ITMI20051910A1 (it) * 2005-10-11 2007-04-12 Anidral Srl Metodo per la preparazione di colture batteriche probiotiche anallergiche e relativo impiego
PL1996696T3 (pl) * 2006-03-17 2017-08-31 Probi Aktiebolag Termostabilne szczepy Lactobacillus
EP2065048A1 (en) * 2007-11-30 2009-06-03 Institut Pasteur Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
FR2937252B1 (fr) 2008-10-17 2011-05-20 Pf Medicament Association d'un extrait de sureau et d'une souche de l. paracasei.
MY147929A (en) * 2009-03-13 2013-02-15 Chan Yap Kee Camera flash reflector assembly

Also Published As

Publication number Publication date
CN103097513B (zh) 2018-01-30
EP2545160B1 (en) 2018-07-18
CN103097513A (zh) 2013-05-08
EP2545160A1 (en) 2013-01-16
BR112012023028B1 (pt) 2020-12-08
US20170145379A1 (en) 2017-05-25
US20130121976A1 (en) 2013-05-16
BR112012023028A2 (pt) 2017-02-07
US10603342B2 (en) 2020-03-31
EA031179B1 (ru) 2018-11-30
ES2691301T3 (es) 2018-11-26
WO2011110884A1 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
EA201290902A1 (ru) Молочно-кислые бактерии, применяемые при чревной болезни
CY1118984T1 (el) Παρασκευη ενεργων, ακρως φωσφορυλιωμενων, ανθρωπινων λυσοσωμικων ενζυμων σουλφατασης και χρησεις αυτων
EA201270571A1 (ru) Человеческие il-23-антигенсвязывающие белки
MX2012007684A (es) Modificacion covalente ligando dirigida de proteina.
EA201490004A1 (ru) Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей
WO2012062810A3 (en) Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
EA201590910A1 (ru) Белки на основе структурного домена фибронектина, связывающие pcsk9
MX2012008999A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340015B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340016B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
NZ603901A (en) Vectors and sequences for the treatment of diseases
EA201391157A1 (ru) Антагонисты pcsk9
PE20140190A1 (es) Moduladores de proteinas notum y metodos de uso
IN2012DN00801A (ru)
AU2011206532A8 (en) Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)
UA112985C2 (uk) Одноланцюговий поліпептидний гібридний білок
CY1121519T1 (el) Καθαρισμος της υδουρονικης-2-σουλφατασης
EA201200515A1 (ru) Полипептиды и их применение
WO2012006384A3 (en) Rothia species gluten-degrading enzymes and uses thereof
ES2402014A1 (es) Peptido secretado por lactobacillus plantarum con función inmunomoduladora
EA201491784A1 (ru) Антитела против лигандов рецептора в1 брадикинина
EP2596122A4 (en) MODULATORS OF SIRT5 AND TESTS FOR SCREENING
WO2011022357A3 (en) Fast acting snare-cleaving enzymes

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM